title: Pulmonary and renal protection: targeting PARP to ventilator-induced lung and kidney injury?
abstract: Both acute lung injury and acute kidney injury (AKI) are frequent and serious problems in intensive care medicine. Therefore, the avoiding of any iatrogenic insult to these organs is of great importance. While an increasing body of evidence suggests that mechanical ventilation is capable of inducing lung and distant organ injury, the complex underlying molecular mechanisms remain insufficiently understood. In the previous issue of Critical Care, Vaschetto and colleagues reported the results of an experimental study designed to further explore pathways linking injurious ventilation with AKI. The authors demonstrated that scavenging of peroxynitrite or inhibiting poly(ADP-ribose) polymerase (PARP) afforded protection against AKI induced by double-hit lung injury. Although PARP inhibition or peroxynitrite detoxification or both may become viable candidates for a protective strategy in this setting, the implementation of a lung-protective ventilatory strategy remains the only clinical tool to mitigate the lung biotrauma and its systemic consequences.
authors.affiliation: 1st Medical Department, Charles University Medical School and Teaching Hospital, alej Svobody 80, 304 60 Plzen, Czech Republic. matejovic@fnplzen.cz
authors.forename: Martin
authors.initials: M
authors.lastname: Matejovic
authors.forename: Peter
authors.initials: P
authors.lastname: Radermacher
mesh_terms: D058186:Acute Kidney Injury / Q000517:prevention & control*; D006801:Humans; D008658:Inactivation, Metabolic; D030421:Peroxynitrous Acid / Q000493:pharmacokinetics; D010616:Phenanthrenes / Q000494:pharmacology*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D055397:Ventilator-Induced Lung Injury / Q000517:prevention & control*
chemical_list: C434926:N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride; D010616:Phenanthrenes; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D030421:Peroxynitrous Acid
references.citation: Curr Opin Crit Care. 2010 Feb;16(1):13-8
references.pmid: 19935063
references.citation: JAMA. 2003 Apr 23-30;289(16):2104-12
references.pmid: 12709468
references.citation: Crit Care. 2008;12(4):R108
references.pmid: 18718025
references.citation: Shock. 2004 May;21(5):458-65
references.pmid: 15087823
references.citation: Am J Respir Cell Mol Biol. 2005 Jan;32(1):52-8
references.pmid: 15388514
references.citation: Curr Opin Anaesthesiol. 2008 Apr;21(2):111-21
references.pmid: 18443476
references.citation: Pharmacol Res. 2005 Jul;52(1):44-59
references.pmid: 15911333
references.citation: Blood Purif. 2010;29(1):52-68
references.pmid: 19923815
references.citation: Intensive Care Med. 2007 May;33(5):845-850
references.pmid: 17361386
references.citation: Curr Opin Crit Care. 2009 Dec;15(6):503-8
references.pmid: 19829106
references.citation: Crit Care Med. 2005 Jun;33(6):1408-15
references.pmid: 15942363
references.citation: Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1721-5
references.pmid: 9620897
references.citation: Nat Rev Nephrol. 2009 Nov;5(11):629-40
references.pmid: 19786992
references.citation: Clin Immunol. 2009 Jan;130(1):41-50
references.pmid: 18922742
references.citation: Am J Kidney Dis. 2002 Mar;39(3):616-24
references.pmid: 11877583
references.citation: Crit Care. 2010;14(2):R45
references.pmid: 20346119
references.citation: Anesthesiology. 2008 Feb;108(2):261-8
references.pmid: 18212571
references.citation: Intensive Care Med. 2004 Oct;30(10):1865-72
references.pmid: 15221129
references.citation: Intensive Care Med. 2006 Oct;32(10):1470-4
references.pmid: 16927074